Author:
Beesley Vanessa L.,Burge Matthew,Dumbrava Monica,Callum Jack,Neale Rachel E.,Wyld David K.
Funder
Novartis Pharmaceuticals Australia
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Dasari A, Shen C, Halperin D, et al. (2017) Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncology 3(10):1335–1342
2. Wyld DK, Wan, M H, Moore, J, editor. Neuroendocrine neoplasm trends over 32 years in Queensland, Australia. European Neuroendocrine Tumour Society Annual Conference; 2017; Barcelona, Spain
3. Modlin IM MS, Oberg K, Padbury R, Hicks RJ, Gustafsson BI, Wright NA, Kidd M (2010) Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management. Med J Australia 193(1):46–52
4. Wyld D, Plage S, Burge M, et al., editors (2017) ‘How long is the piece of string?’—how patients negotiate the uncertainties of a neuroendocrine tumour diagnosis. Cancer Survivorship Conference. Adelaide, Australia http://www.survivorship2017.org
5. Plage S, Gibson A, Burge M, Wyld D. Cancer on the margins: experiences of living with neuroendocrine tumours. Health Sociology Review 2017 Oct 1 https://doi.org/10.1080/14461242.2017.1387068
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献